Cowen And Company, LLC Mesoblast LTD Transaction History

Cowen And Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.87 - $7.85 $336,351 - $449,805	-57,300 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$6.69 - $9.0 $613,473 - $825,300	-91,700 Reduced 61.54%	57,300 $429,000
Q1 2021 May 04, 2021	SELL	$8.26 - $11.4 $413,000 - $570,000	-50,000 Reduced 25.13%	149,000 $1.23 Million
Q4 2020 Feb 08, 2021	SELL	$8.21 - $18.59 $500,810 - $1.13 Million	-61,000 Reduced 23.46%	199,000 $1.69 Million
Q3 2020 Nov 03, 2020	BUY	$11.33 - $19.81 $2.95 Million - $5.15 Million	260,000 New	260,000 $4.83 Million

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.